- The folks at Northwestern University are studying the effects of capecitabine; yttrium Y 90 glass microspheres on Metastatic Cancer and Liver Cancer in individuals ages 18 years and older. This clinical trial is slated to start March 2009 and is expected to end circa December 2015.312-695-4440 Mary Mulcahy, MD
|Recruiting||Mary Mulcahy, MDfirstname.lastname@example.org||312-695-4440|
This study is officially titled, "Dose Escalating Study of Yttrium 90 Microspheres (TheraSphere) With Capecitabine (Xeloda) for Intrahepatic Cholangiocarcinoma or Metastatic Disease to the Liver."
Chicago, Illinois, 60611
United States - map
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.